Personalized kidney stone prevention plans that are based on testing each person’s urine work significantly better than generic advice. According to Gram Research analysis of decades of studies, targeted treatment reduces stone recurrence by 45 to 75 percent depending on the intervention, with increased fluid intake cutting risk by roughly half and medicines like potassium citrate reducing it by up to 75 percent. This personalized approach is especially effective for people who have had multiple stones or just had surgery.
People who get kidney stones often get them again, but a new review shows that personalized treatment plans work much better than generic advice. Researchers looked at decades of studies to see if testing each person’s urine and then giving them a custom plan (including diet changes and specific medicines) actually prevents stones from coming back. The answer is yes: personalized approaches cut stone recurrence in half or more, especially for people who have had multiple stones. This matters because kidney stones are painful, expensive, and bad for quality of life.
Key Statistics
A narrative review of studies from 1980 to 2026 found that increased fluid intake reduces kidney stone recurrence risk by 45 to 55 percent compared to normal fluid intake in adults with a history of stones.
In a 2026 narrative review, potassium citrate therapy reduced stone recurrence risk by approximately 75 percent in patients with specific urine abnormalities, compared to no targeted treatment.
A 2026 narrative review found that a diet normal in calcium but reduced in sodium and animal protein achieves a 49 percent reduction in stone recurrence for people with high urinary calcium and calcium-oxalate stones.
The rigorous NOSTONE trial cited in a 2026 narrative review found that thiazide diuretics reduced stone recurrence risk by 48 percent, lower than earlier studies had suggested, showing that treatment effectiveness can vary.
The Quick Take
- What they studied: Whether personalized kidney stone prevention plans (based on testing each person’s urine) work better than giving everyone the same generic advice
- Who participated: This was a review of many studies done between 1980 and 2026 involving adults who had kidney stones or were at risk for them
- Key finding: Personalized treatment plans that target each person’s specific urine problems reduce stone recurrence by 50 to 75 percent, depending on the treatment used
- What it means for you: If you have had kidney stones, getting tested to find out exactly what is wrong with your urine, then following a custom plan, gives you the best chance of avoiding stones in the future. This is especially true if you have had multiple stones or just had surgery to remove them.
The Research Details
This was a narrative review, which means researchers read through many published studies and clinical guidelines from 1980 to March 2026 to summarize what we know about kidney stone prevention. They searched major medical databases including PubMed and the Cochrane Library, which contains high-quality research summaries. They looked for randomized trials (the gold standard where people are randomly assigned to different treatments), controlled studies (where one group gets treatment and another does not), and systematic reviews (summaries of many studies on the same topic). They also included official guidance from major urology organizations in Europe and America.
The researchers focused on whether testing a person’s urine to find specific abnormalities, then giving them targeted treatment based on those results, actually prevents kidney stones from coming back. They looked at different types of interventions: lifestyle changes like drinking more water or changing diet, and medicines like potassium citrate or thiazide diuretics.
This approach is different from empirical therapy, which means giving everyone the same treatment without first testing to see what their specific problem is. The review examined whether the personalized approach works better, especially for people at high risk of getting stones again.
A narrative review is useful because it pulls together decades of research to answer a practical question: should doctors test each patient’s urine and customize treatment, or is generic advice good enough? This matters because kidney stone prevention is expensive and time-consuming, so we need to know which approach actually works best. The review also looked at whether personalized prevention improves quality of life and saves money overall.
This review included randomized controlled trials and systematic reviews, which are the most reliable types of studies. However, a narrative review is less rigorous than a systematic review because the researchers chose which studies to include based on their judgment rather than using a strict, predetermined formula. The review does cite the NOSTONE trial, which was a large, rigorous study that tested thiazide medicines and found they did not work as well as expected. This shows the authors are being honest about cases where treatments did not work as well as hoped.
What the Results Show
Gram Research analysis shows that personalized metabolic investigation and targeted treatment significantly reduces kidney stone recurrence across multiple intervention types. Increased fluid intake alone cuts stone recurrence risk by roughly 45 to 55 percent compared to normal fluid intake. For people with high calcium in their urine and calcium-oxalate stones, a diet that is normal in calcium but low in sodium and animal protein achieves a similar 49 percent reduction in recurrence.
When medicines are added to target specific urine abnormalities, the results improve further. Potassium citrate reduces recurrence risk by about 75 percent, thiazide diuretics by about 48 percent, and allopurinol by about 41 percent. However, the rigorous NOSTONE trial found that thiazides did not work as well in practice as earlier studies suggested, showing that even well-studied treatments do not always perform as expected.
After surgery to remove kidney stones (either shockwave lithotripsy or percutaneous nephrolithotomy), medical therapy reduces the chance that new stones will form or that leftover stone pieces will grow back. The evidence that personalized, urine-directed therapy outperforms one-size-fits-all treatment is strongest in high-risk patients, meaning those who have had multiple stones or have severe urine abnormalities. In these patients, selective treatment based on test results produces significantly fewer stone-related events than empirical therapy.
The review found that kidney stone disease significantly harms disease-specific quality of life, meaning people with stones report worse health and well-being. Stone disease is also very costly, both in direct medical expenses and in lost productivity. Therefore, preventing stone recurrence is cost-saving for both patients and the healthcare system. The review emphasizes that the case for personalized prevention is strongest in three groups: people with recurrent stones, high-risk patients with severe urine abnormalities, and people recovering from stone removal surgery.
This review synthesizes evidence from decades of research and aligns with guidance from major urology organizations including the European Association of Urology, American Urological Association, National Institute for Health and Care Excellence, and American College of Physicians. The findings confirm that targeted interventions work better than generic advice, but the review also highlights that some treatments (like thiazides) have not lived up to earlier expectations, showing that the field is evolving as new rigorous trials are completed.
This is a narrative review rather than a systematic review, so the selection of studies was based on the authors’ judgment rather than a strict formula. This means some relevant studies might have been missed or others overemphasized. The review does not provide a sample size because it synthesizes many studies of varying sizes. The evidence for personalized therapy is strongest in high-risk patients, so the benefits may be smaller for people with only one stone or mild urine abnormalities. Finally, the review notes that adherence to treatment is critical, but many studies do not measure how well patients actually follow their prescribed plans.
The Bottom Line
If you have had kidney stones, ask your doctor for a 24-hour urine test to identify your specific urine abnormality (high confidence recommendation). Based on the results, follow a personalized plan that may include drinking more water, changing your diet, and taking a targeted medicine if needed (high confidence). After stone removal surgery, medical therapy should be continued to prevent new stones and stop leftover pieces from growing (high confidence). Repeat testing after 3 to 6 months to confirm that your treatment is working and adjust if needed (moderate confidence).
This approach is most important for people who have had multiple kidney stones, people with severe urine abnormalities, and people recovering from stone removal surgery. People with a single stone and no known urine abnormality may benefit from general advice like drinking more water, but may not need extensive testing. People with a family history of kidney stones or those with certain genetic conditions should also consider personalized investigation.
You should see reduced stone formation within 6 to 12 months if your treatment is working. Quality of life improvements may be noticed sooner as you gain confidence that your plan is preventing stones. Long-term benefits accumulate over years as you avoid the pain, surgery, and costs of recurrent stones.
Frequently Asked Questions
Does personalized kidney stone prevention actually work better than just drinking more water?
Yes. While drinking more water cuts recurrence risk by about 50 percent, adding a personalized plan based on urine testing and targeted medicines can reduce risk by 75 percent or more. Personalized treatment works best for high-risk patients with multiple stones.
What should I do after kidney stone surgery to prevent stones from coming back?
Medical therapy after surgery reduces new stone formation and prevents leftover stone pieces from growing. Follow a personalized plan based on your urine test results, which may include increased fluid intake, diet changes, and targeted medicines. Repeat testing after 3 to 6 months confirms your treatment is working.
How much should I drink if I have had kidney stones?
Aim for 2.5 to 3 liters of fluid per day, which roughly halves stone recurrence risk. Your doctor may recommend a different amount based on your urine test results and the type of stones you form. Pale yellow urine indicates good hydration.
Can diet changes alone prevent kidney stones from coming back?
Diet changes can significantly reduce recurrence, especially for people with high urinary calcium. A diet normal in calcium but low in sodium and animal protein cuts recurrence risk by about 49 percent. However, combining diet with increased fluid intake and targeted medicines works better than diet alone.
Who needs personalized kidney stone prevention testing?
Personalized testing is most important for people with multiple kidney stones, those with severe urine abnormalities, and people recovering from stone removal surgery. People with a single stone may benefit from general advice like drinking more water without extensive testing.
Want to Apply This Research?
- Log daily fluid intake in ounces and track urine color (pale yellow indicates good hydration). Set a goal of 2.5 to 3 liters per day and monitor whether you hit it. Record any stone-related symptoms or discomfort to share with your doctor.
- Set daily reminders to drink water at regular intervals (for example, 8 ounces every 2 hours). Use the app to log meals and flag high-sodium or high-animal-protein foods so you can see patterns. If prescribed a medicine like potassium citrate, set a daily reminder to take it and log adherence.
- Track adherence to your personalized plan weekly. Every 3 to 6 months, record the results of your repeat 24-hour urine test in the app to confirm that your treatment is working. If results are not improving, use the app to identify which parts of your plan you may not be following, then adjust with your doctor’s help.
This article summarizes research on kidney stone prevention and should not replace professional medical advice. If you have had kidney stones or suspect you may have one, consult a urologist or your primary care doctor for personalized evaluation and treatment. Do not start, stop, or change any medications without your doctor’s approval. This review reflects evidence available through March 2026 and may not include the most recent studies. Individual results vary based on the type of stones, underlying medical conditions, and adherence to treatment plans.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.